These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2550572)

  • 21. Regulation by recombinant interleukin-2 of protective immunity against recurrent herpes simplex virus type 2 genital infection in guinea pigs.
    Weinberg A; Konrad M; Merigan TC
    J Virol; 1987 Jul; 61(7):2120-7. PubMed ID: 3035213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ability of herpes simplex virus (HSV) types 1 and 2 to induce clinical disease and establish latency following previous genital infection with the heterologous HSV type.
    Landry ML; Zibello TA
    J Infect Dis; 1988 Dec; 158(6):1220-6. PubMed ID: 2848899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secretory IgA antibody in cervicovaginal secretions from women with genital infection due to herpes simplex virus.
    Merriman H; Woods S; Winter C; Fahnlander A; Corey L
    J Infect Dis; 1984 Apr; 149(4):505-10. PubMed ID: 6327834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
    Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
    Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute genital infection in guinea pigs: effect of recombinant interleukin-2 on herpes simplex virus type 2.
    Weinberg A; Rasmussen L; Merigan TC
    J Infect Dis; 1986 Jul; 154(1):134-40. PubMed ID: 3011918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes.
    Sullender WM; Yasukawa LL; Schwartz M; Pereira L; Hensleigh PA; Prober CG; Arvin AM
    J Infect Dis; 1988 Jan; 157(1):164-71. PubMed ID: 2826604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent genital infection in the guinea pig: differences between herpes simplex types 1 and 2.
    Landry ML; Myerson D; Bull C
    Intervirology; 1992; 34(4):169-79. PubMed ID: 1339184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-mediated immunologic responses and recurrent genital herpes in the guinea pig. Effects of glycoprotein immunotherapy.
    Bernstein DI; Harrison CJ; Jenski LJ; Myers MG; Stanberry LR
    J Immunol; 1991 May; 146(10):3571-7. PubMed ID: 1851194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.
    Bourne N; Bravo FJ; Francotte M; Bernstein DI; Myers MG; Slaoui M; Stanberry LR
    J Infect Dis; 2003 Feb; 187(4):542-9. PubMed ID: 12599070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Confirmation of herpes simplex virus type 2 infections in herpes-like genital lesions by a simple complement-fixation test.
    Arsenakis M; May JT
    Br J Vener Dis; 1982 Feb; 58(1):48-51. PubMed ID: 6275941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs.
    Harrison CJ; Miller RL; Bernstein DI
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2059-64. PubMed ID: 7811019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection.
    Harrison CJ; Jenski L; Voychehovski T; Bernstein DI
    Antiviral Res; 1988 Dec; 10(4-5):209-23. PubMed ID: 2465735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of guinea-pig immune functions by interleukin 2: critical role of natural killer activity in acute HSV-2 genital infection.
    Weinberg A; Basham TY; Merigan TC
    J Immunol; 1986 Nov; 137(10):3310-7. PubMed ID: 3021853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of shRNA-containing herpes simplex virus type 1 (HSV-1)-based gene therapy for HSV-2-induced genital herpes.
    Liu Z; Xiang Y; Wei Z; Yu B; Shao Y; Zhang J; Yang H; Li M; Guan M; Wan J; Zhang W
    J Virol Methods; 2013 Nov; 193(2):353-8. PubMed ID: 23845900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential genital infections by herpes simplex viruses types 1 and 2: restriction nuclease analyses of viruses from recurrent infections.
    Kit S; Trkula D; Qavi H; Dreesman G; Kennedy RC; Adler-Storthz K; Kaufman R; Adam E
    Sex Transm Dis; 1983; 10(2):67-71. PubMed ID: 6318371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination with a HSV-2 UL24 mutant induces a protective immune response in murine and guinea pig vaginal infection models.
    Visalli RJ; Natuk RJ; Kowalski J; Guo M; Blakeney S; Gangolli S; Cooper D
    Vaccine; 2014 Mar; 32(12):1398-406. PubMed ID: 24462481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease.
    Da Costa XJ; Bourne N; Stanberry LR; Knipe DM
    Virology; 1997 May; 232(1):1-12. PubMed ID: 9185583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymptomatic vaginal herpes simplex virus infections in mice: virology and pathohistology.
    Podlech J; Hengerer F; Fleck M; Eray K; D Falke
    Arch Virol; 1996; 141(2):263-74. PubMed ID: 8634019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of acyclovir on genital herpes in guinea pigs.
    Pronovost AD; Lucia HL; Dann PR; Hsiung GD
    J Infect Dis; 1982 Jun; 145(6):904-8. PubMed ID: 6282986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel deletion in glycoprotein G forms a cluster and causes epidemiologic spread of herpes simplex virus type 2 infection.
    Daikoku T; Horiba K; Kawana T; Hirano M; Shiraki K
    J Med Virol; 2013 Oct; 85(10):1818-28. PubMed ID: 23861013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.